Presentation CIT 2019

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Scaffold in Patients with Coronary Artery Disease (FUTURE-I) 3-Year Clinical and Imaging Outcomes

Presenter: Bo Xu

REGISTER for free or LOG IN to view this content

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Scaffold in Patients with Coronary Artery Disease (FUTURE-I) 3-Year Clinical and Imaging Outcomes
Coronary
Presentation
CIT 2019
Sirolimus
Bioresorbable Scaffolds
Coronary Artery Disease

Up Next

More slides +

We Recommend